Tempus AI (NASDAQ:TEM) PT Raised to $57.00

Tempus AI (NASDAQ:TEM - Get Free Report) had its price target upped by research analysts at Loop Capital from $48.00 to $57.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a "buy" rating on the stock. Loop Capital's price target points to a potential upside of 22.24% from the company's previous close.

A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. upped their price target on Tempus AI from $42.00 to $47.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Needham & Company LLC reissued a "buy" rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Morgan Stanley started coverage on Tempus AI in a report on Tuesday, July 9th. They issued an "overweight" rating and a $44.00 target price on the stock. Longbow Research started coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $48.00 target price on the stock. Finally, Stifel Nicolaus started coverage on Tempus AI in a report on Tuesday, July 9th. They issued a "buy" rating and a $45.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, Tempus AI has a consensus rating of "Moderate Buy" and a consensus price target of $48.67.

Tempus AI Trading Down 8.1 %

Tempus AI stock traded down $4.09 during mid-day trading on Tuesday, hitting $46.63. The company had a trading volume of 1,405,091 shares, compared to its average volume of 1,173,399. The company has a current ratio of 3.70, a quick ratio of 3.52 and a debt-to-equity ratio of 4.50. The business has a 50 day simple moving average of $51.67. Tempus AI has a 12 month low of $22.89 and a 12 month high of $77.00.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. As a group, equities analysts predict that Tempus AI will post -6.51 earnings per share for the current fiscal year.

Institutional Trading of Tempus AI

Several institutional investors have recently made changes to their positions in TEM. Sandia Investment Management LP purchased a new stake in shares of Tempus AI during the second quarter worth about $136,000. Northwestern University purchased a new stake in shares of Tempus AI during the second quarter worth about $491,000. Squarepoint Ops LLC purchased a new stake in shares of Tempus AI during the second quarter worth about $633,000. WINTON GROUP Ltd purchased a new stake in shares of Tempus AI during the second quarter worth about $634,000. Finally, Scientech Research LLC bought a new position in Tempus AI during the second quarter valued at approximately $756,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.